SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-024741
Filing Date
2022-11-14
Accepted
2022-11-14 08:37:36
Documents
18
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ymtx-20221110.htm   iXBRL 8-K 111534
2 EX-99.1 ymtx-ex99_1.htm EX-99.1 173993
3 EX-99.2 ymtx-ex99_2.htm EX-99.2 40486
4 EX-99.3 ymtx-ex99_3.htm EX-99.3 15351
5 GRAPHIC img223686093_0.jpg GRAPHIC 12304
6 GRAPHIC img224609614_0.jpg GRAPHIC 12312
7 GRAPHIC img225533135_0.jpg GRAPHIC 7593
  Complete submission text file 0000950170-22-024741.txt   534750

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ymtx-20221110_lab.xml EX-101.LAB 13896
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ymtx-20221110.xsd EX-101.SCH 2462
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ymtx-20221110_pre.xml EX-101.PRE 11374
12 EXTRACTED XBRL INSTANCE DOCUMENT ymtx-20221110_htm.xml XML 4706
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 221380658
SIC: 2834 Pharmaceutical Preparations